Peripheral Nerve Injuries Market Report 2025

This Peripheral Nerve Injuries market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The peripheral nerve injuries market size has grown rapidly in recent years. It will grow from $3.93 billion in 2024 to $4.44 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to increased age-related disorders, such as osteoporosis and arthritis.

The peripheral nerve injuries market size is expected to see rapid growth in the next few years. It will grow to $7.12 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing incidence trauma, accidents, sports injuries, increasing chronic conditions like diabetes, increasing aging population, increasing patient compliance, and improving quality of life, rising prevalence of peripheral nerve injuries (PNI) globally. Major trends in the forecast period include technological advancements in nerve repair, advancements in diagnostic technologies, development of artificial nerve implant, emerging therapies, focus on personalized medicine.

The rising number of accidents is expected to fuel the growth of the peripheral nerve injuries market in the future. This increase in accidents can be attributed to various factors, including urbanization, which leads to higher traffic volumes, lifestyle changes, environmental conditions, and distracted behaviors. Peripheral nerve injuries often require comprehensive treatment approaches to reduce their effects and promote recovery. Emerging treatments such as stem cell therapy, growth factor administration, and gene therapy show promise for improving nerve regeneration and functional recovery in accident-related injuries. For example, in May 2023, the Department for Transport, a UK government agency, reported that the number of fatalities on UK roads rose from 1,560 in 2021 to 1,695 in 2022. As a result, the growing incidence of accidents is driving the peripheral nerve injuries market.

The growing use of minimally invasive surgeries is expected to drive the expansion of the peripheral nerve injuries market in the coming years. Minimally invasive surgeries involve small incisions, specialized tools, and advanced imaging techniques, aiming to reduce patient recovery time, pain, and the risk of complications. The rise in these surgeries is driven by factors such as shorter recovery times, lower complication risks, and improved patient outcomes. Treating peripheral nerve injuries requires precise, targeted techniques to prevent damage to surrounding tissues, leading to the development of advanced surgical tools like robotic systems, endoscopic instruments, and precision-guided technologies. These innovations allow for more accurate procedures with minimal incisions, lowering the risk of nerve damage and enhancing recovery. For example, in August 2023, The Aesthetic Society, a U.S.-based organization of plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures, a 2% increase from the previous year. As a result, the rise in minimally invasive surgeries is driving the growth of the peripheral nerve injuries market.

Key players in the peripheral nerve injuries market are channeling investments into research and development of nerve injury therapeutics, aiming to improve nerve regeneration, enhance functional outcomes, and address the unmet medical needs of affected patients. These investments fuel progress and innovation in the peripheral nerve injuries market, leading to the creation of advanced therapies, better patient outcomes, and improved quality of life for individuals grappling with nerve injuries. For instance, in October 2022, NervGen Pharma Corp., a Canadian pharmaceutical company, secured funding of up to $1.5 million from the US Department of Defense (DoD) to assess its investigational therapeutic NVG-291-R for peripheral nerve injury (PNI) treatment. This funding would support preclinical research to demonstrate the efficacy of NVG-291-R in enhancing nerve regeneration post-PNI.

Major companies operating in the peripheral nerve injuries market are Abbott Laboratories, Medtronic Plc, Stryker Corporation, Boston Scientific Corporation, Integra LifeSciences Holdings Corp., Bioventus LLC, MicroPort Scientific Corporation, Nevro Corp., AxoGen Inc., Bioness Inc., SPR Therapeutics Inc., Stimwave Technologies Inc., SetPoint Medical Inc., NeuroMetrix Inc., Polyganics BV, Regenity Biosciences, Renerva LLC, Aleva Neurotherapeutics SA, Neuraptive Therapeutics Inc., Neuros Medical Inc., Synapse Biomedical Inc., Orthocell Ltd., NeuraLace Medical Inc., MyndTec Inc., Epineuron LLC.

North America was the largest region in the peripheral nerve injuries market in 2024. The regions covered in the peripheral nerve injuries market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the peripheral nerve injuries market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Peripheral nerve injury encompasses any damage or impairment affecting the peripheral nerves, which are the nerves situated outside the brain and spinal cord. These nerves play a vital role in transmitting signals between the central nervous system (CNS) and the rest of the body, facilitating sensation, movement, and motor coordination.

The primary product categories for addressing peripheral nerve injuries include nerve conduits, nerve protectors, nerve connectors, and nerve wraps. Nerve protectors are medical devices or materials utilized to shield and safeguard nerves from harm or injury during surgical procedures. Various types of injuries, such as traumatic, compression, and surgical injuries, are treated through diverse surgical interventions such as direct nerve repair, nerve grafting, and stem cell therapy. These interventions find application in a range of areas such as upper extremities and lower extremities, catering to diverse end-users including hospitals and clinics, rehabilitation centers, and home care settings.

The peripheral nerve injury market research report is one of a series of new reports that provides peripheral nerve injury market statistics, including peripheral nerve injury industry global market size, regional shares, competitors with a peripheral nerve injury market share, detailed peripheral nerve injury market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral nerve injury industry. This peripheral nerve injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peripheral nerve injuries market consists of sales of nerve injury medications, gene therapies, and stem cell therapy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.